Side effects of androgen deprivation therapy: monitoring and minimizing toxicity
CS Higano - Urology, 2003 - Elsevier
The current trends in favor of androgen deprivation therapy (ADT) for nonmetastatic prostate
cancer at the stage of biochemical recurrence or increasing prostate-specific antigen (PSA) …
cancer at the stage of biochemical recurrence or increasing prostate-specific antigen (PSA) …
[HTML][HTML] Current and future trends in men's health clinics
JJ Houman, SV Eleswarapu, JN Mills - Translational andrology and …, 2020 - ncbi.nlm.nih.gov
Men's health is a unique field that requires a multi-disciplinary approach to appropriately
treat the full spectrum of men's health needs. Given that interest in men's health is relatively …
treat the full spectrum of men's health needs. Given that interest in men's health is relatively …
Method and composition for transdermal drug delivery
T DiPietro, A Humberstone, I Gonda… - US Patent …, 2013 - Google Patents
The invention is directed to a transdermal drug delivery com position which includes at least
one physiologically active agent; and at least one volatile solvent; and at least one vis cosity …
one physiologically active agent; and at least one volatile solvent; and at least one vis cosity …
Transdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome
HD White, R Gyurik - US Patent 7,799,769, 2010 - Google Patents
6,319,913 B1 1 1/2001 Mak et al. WO WO O2/O89849 11, 2002 6,503,894 B1 1/2003
Dudley WO WOO3, 002123 1, 2003 6,743,448 B2 6/2004 Kryger WO WOO3, O28667 …
Dudley WO WOO3, 002123 1, 2003 6,743,448 B2 6/2004 Kryger WO WOO3, O28667 …
Near-infrared spectroscopy for the determination of testosterone in thin-film composites
W Fountain, K Dumstorf, AE Lowell, RA Lodder… - … of pharmaceutical and …, 2003 - Elsevier
More rapid, reproducible, and cost-effective methods to control product quality in the
pharmaceutical industry continue to be a major emphasis, particularly with the FDA through …
pharmaceutical industry continue to be a major emphasis, particularly with the FDA through …
Transmucosal delivery of testosterone in rabbits using novel bi‐layer mucoadhesive wax‐film composite disks
Testosterone exhibits very low oral bioavailability because of its low aqueous solubility and
extensive first‐pass metabolism. The purpose of this study was to develop a novel bi‐layer …
extensive first‐pass metabolism. The purpose of this study was to develop a novel bi‐layer …
Human immunodeficiency virus and depression in primary care: a clinical review
T Colibazzi, TT Hsu, WS Gilmer - Prim Care Companion J Clin …, 2006 - psychiatrist.com
Background: Human immunodeficiency virus (HIV)–infected individuals are at increased risk
of developing depression. Depressive syndromes in these patients pose a challenge both …
of developing depression. Depressive syndromes in these patients pose a challenge both …
Selective androgen receptor modulators (SARMs)
L Zhi, E Martinborough - 2001 - Elsevier
Publisher Summary This chapter examines the different aspects of selective androgen
receptor modulators (SARMS). Testosterone (T) is an endogenous ligand for the androgen …
receptor modulators (SARMS). Testosterone (T) is an endogenous ligand for the androgen …
Testosterone gel and method of use
R Malladi, J Stahlman - US Patent 8,466,136, 2013 - Google Patents
The present invention relates to an improved transdermal hydroalcoholic testosterone gen
formulation that provides, among other things, a desirable pharmacokinetic hormone profile …
formulation that provides, among other things, a desirable pharmacokinetic hormone profile …
Benefits of a new testosterone gel formulation for hypogonadal men
JC Kaminetsky - Clinical cornerstone, 2005 - Elsevier
Hypogonadism is a common problem in men. It affects 2% to 30% of men aged 40 to 59
years, 20% to 45% aged 60 to 69 years, 34% to 70% aged 70 to 79 years, and most men …
years, 20% to 45% aged 60 to 69 years, 34% to 70% aged 70 to 79 years, and most men …